Turkiye Klinikleri Journal of Medical Ethics-Law and History

.: RESEARCH
Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?
Tıp Fakülteleri Ders Programlarında Farmakovijilans ve Akılcı Farmakoterapi ile İlişkili Konuların Kapsanması Gelecekteki Doktorlar Açısından Yeterli Midir?
Müberra Devrim GÜNERa, Perihan Elif EKMEKCİb
Departments of
aMedical Pharmacology,
bHistory of Medicine and Ethics, TOBB Economy and Technology University Faculty of Medicine, Ankara, TURKEY
Turkiye Klinikleri J Med Ethics. 2019;27(3):186-95
doi: 10.5336/mdethic.2019-66097
Article Language: EN
Full Text
ABSTRACT
 Underreporting of adverse drug reactions (ADRs) is a global problem and the main reasons for not reporting ADRs are either failure to recognize an ADR or failure to report the recognized ADR, which can be prevented by efficient education and training. Thus, the content on pharmacovigilance and related subjects in the curricula of the medical schools was evaluated. The web pages of the 63 Turkish medical schools that provided online curricula were evaluated for the following subjects: pharmacovigilance, toxicology, rational pharmacotherapy, drug use in special populations, good prescription writing principles, and clinical pharmacology stage. The number of hours dedicated to these subjects and the year of the course during which these subjects were taught were recorded. Of the 63 medical schools, 41 (65.1%) provide pharmacovigilance course and 33 (52.4%) rational pharmacotherapy course for 0.5-2 hours, mostly during the 3rd year of education. Thirty of the medical schools (47.6%) had clinical pharmacology and rational pharmacotherapy stage covering personal-drug selection, and clinical pharmacology of organ-systems was mostly a five-day course during the 4th or 5th years of education. The time allocated for pharmacovigilance and related subjects in the curricula of medical schools is not sufficient for the students to acquire satisfactory knowledge on ADR and to influence their attitudes as physicians in the future. In order to improve this, more time and effort must be allocated by medical schools to pharmacovigilance and rational pharmacotherapy education, particularly during the later years of medical education.

Keywords: Pharmacovigilance; pharmacology education; clinical pharmacology; rational pharmacotherapy; adverse drug reaction reporting
ÖZET
 Advers ilaç reaksiyonlarının (AİR) yeterince bildirilmemesi küresel bir sorundur ve bildirmemenin temel nedenleri AİR'lerin fark edilmemesi veya fark edilse bile bildirilmemesidir. Bu durumun üstesinden ancak yeterli eğitim ile gelinebilir. Tıp fakülteleri ders programlarında farmakovijilans ve ilgili konuların varlığı bu nedenle değerlendirildi. Türkiye'de bulunan tıp fakültelerinin 63'ü web sayfalarında ayrıntılı ders programlarını paylaşmaktadır. Bu ders programları şu konuların varlığı açısından incelenmiştir: farmakovijilans, toksikoloji, akılcı farmakoterapi, özel popülasyonlarda ilaç kullanımı, iyi reçete yazma kuralları, klinik farmakoloji stajı. Bu konuların hangi sınıfta öğretildiği ve ne kadar süre ayrıldığı kaydedilmiştir. İncelenen 63 tıp fakültesinden 41'i (%65,1) farmakovijilans dersini ve 33'ü (%52,4) akılcı farmakoterapi dersini 0,5-2 saat süre ile ve genellikle 3. sınıfta sunmaktadır. Otuz (%47,6) okul genellikle 4 veya 5. sınıfta beş iş günü süren klinik farmakoloji ve akılcı farmakoterapi stajı vermektedir ve bu staj sırasında kişisel ilaç seçimi, organsisteme özgü ilaçların klinik farmakolojisi gibi konular kapsanmaktadır. Tıp fakülteleri eğitim programında farmakovijilans ve ilgili konulara ayrılan süre tıp öğrencisinin AİR ile ilgili tatmin edici düzeyde bilgi sahibi olması ve gelecekteki doktorlar olarak gerekli davranışı edinebilmeleri için yeterli değildir. Bu durumu düzeltmek için tıp eğitiminde farmakovijilans ve akılcı farmakoterapiye daha fazla zaman ve emek, özellikle tıp eğitiminin son yıllarında verilmelidir.

Anahtar Kelimeler: Farmakovijilans; farmakoloji eğitimi; klinik farmakoloji; akılcı ilaç tedavisi; advers ilaç reaksiyonu bildirimi
REFERENCES:
  1. Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5): 434-5. [PubMed] 
  2. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-96. [Crossref] [PubMed] 
  3. Aagaard L, Strandell J, Melskens L, Petersen PS, Holme Hansen E. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase?. Drug Saf. 2012;35(12):1171-82. [Crossref] [PubMed] 
  4. Dal Pan GJ. Ongoing challenges in pharmacovigilance. Drug Saf. 2014;37(1):1-8. [Crossref] [PubMed] 
  5. Hohl CM, Small SS, Peddie D, Badke K, Bailey C, Balka E. Why clinicians don't report adverse drug events: qualitative study. JMIR Public Health Surveill. 2018;4(1):e21. [Crossref] [PubMed] [PMC] 
  6. Güner MD, Ekmekci PE. Healthcare professionals? pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13-20. [Crossref] [PubMed] [PMC] 
  7. Kaeding M, Schmälter J, Klika C. Pharmacovigilance in the European Union. Practical Implementation Across Member States. New York: Springer; 2017. p.124. [Crossref] 
  8. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329(7456):15-9. [Crossref] [PubMed] [PMC] 
  9. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM; HARM Study Group. Frequency of and risk factors for preventable medication related hospital admissions in The Netherlands. Arch Intern Med. 2008;168(17):1890-6. [PubMed] 
  10. Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse drug reaction related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847-57. [Crossref] [PubMed] 
  11. Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs Real World Outcomes. 2016;3(1):33-43. [Crossref] [PubMed] [PMC] 
  12. Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317-28. [Crossref] [PubMed] 
  13. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19-31. [Crossref] [PubMed] 
  14. de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing-a practical manual. Geneva: World Health Organization Action Programme on Essential Drugs; 1994. p.123.
  15. Hartman J, Härmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(7):891-9. [Crossref] [PubMed] 
  16. Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235-48. [Crossref] [PubMed] [PMC] 
  17. Pagotto C, Varallo F, Mastroianni P. Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care. 2013;29(4):410-7. [Crossref] [PubMed] 
  18. Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009;32(1):77-83. [Crossref] [PubMed] 
  19. Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086-93. [Crossref] [PubMed] 
  20. Herdeiro MT, Polónia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31(4):335-44. [Crossref] [PubMed] 
  21. Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Polónia J, Falcão A, Figueiras A. Workshop-and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf. 2012;35(8):655-65. [Crossref] [PubMed] 
  22. Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods. Drug Saf. 2011;34(9):755-62. [Crossref] [PubMed] 
  23. Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM, Hadi MA. Pharmacy student's knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75(5):96. [Crossref] [PubMed] [PMC] 
  24. Maxwell SR. How should teaching of undergraduates in clinical pharmacology and therapeutics be delivered and assessed? Br J Clin Pharmacol. 2012;73(6):893-9. [Crossref] [PubMed] [PMC] 
  25. Arici MA, Gelal A, Demiral Y, Tuncok Y. Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students. Indian J Pharmacol. 2015;47(4):436-9. [Crossref] [PubMed] [PMC] 
  26. Umair Khan M, Ahmad A, Ejaz A, Ata Rizvi S, Sardar A, Hussain K, et al. Comparison of the knowledge, attitudes and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof. 2015;12:28. [Crossref] [PubMed] [PMC] 
  27. Abubakar AR, Haque M. Pharmacovigilance practice: the current challenges and the gaps in the medical students' curriculum. J App Pharm Sci. 2016;6(5):210-5. [Crossref] 
  28. Othman GQ, Ibrahim MIM, Alshakka M, Ansari M, Al-Qadasi F, Halboup AM. Knowledge and perception about pharmacovigilance among pharmacy students of universities in Sana's Yemen. J Clin Diagn Res. 2017;11(6):FC09-13. [Crossref] [PubMed] [PMC] 
  29. Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, et al; Education Committee/Working Group Research in Education of the Dutch Society of Clinical Pharmacology and Biopharmacy (NVKF&B), Utrecht, The Netherlands. Pharmacovigilance skills, knowledge and attitudes in our future doctors-a nationwide study in the Netherlands. Basic Clin Pharmacol Toxicol. 2017;120(5):475-81. [Crossref] [PubMed] 
  30. Durrieu G, Hurault C, Damase-Michel C, Montastruc JL. Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students. Fundam Clin Pharmacol. 2010;24(4):423-7. [Crossref] [PubMed] 
  31. Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48(Suppl 1):S69-73. [Crossref] [PubMed] [PMC] 
  32. King M, Khan S. The development and piloting of "ATTEND DR," a clinical teaching tool to identify and prioritize potential causes of adverse drug reactions. Curr Pharm Teach Learn. 2017;9(1):66-71. [Crossref] [PubMed] 
  33. Patel PB, Patel TK, Anturlikar S, Khatun S, Bhabhor P, Saurabh MK. Adverse drug reactions reporting by undergraduate medical students in a tertiary care teaching hospital of India: content and quality analysis in comparison to physician reporting. Perspect Clin Res. 2017;8(3):137-44. [PubMed] 
  34. Bracchi RC, Houghton J, Woods FJ, Thomas S, Smail SA, Routledge PA. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. Br J Clin Pharmacol. 2005;60(2):221-3. [Crossref] [PubMed] [PMC] 
  35. Johansson-Pajala RM, Martin L, Fastbom J, Jorsäter Blomgren K. Nurses' self-reported medication competence in relation to their pharmacovigilant activities in clinical practice. J Eval Clin Pract. 2015;21(1):145-52. [Crossref] [PubMed] 
  36. Ribeiro-Vaz I, Santos CC, Cruz-Correia R. Promoting adverse drug reaction reporting: comparison of different approaches. Rev Saude Publica. 2016;50:14. [Crossref] [PubMed] [PMC] 
  37. Ribeiro-Vaz I, Herdeiro MT, Polónia J, Figueiras A. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica. 2011;45(1):129-35. [Crossref] [PubMed] 
  38. van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003-11. [Crossref] [PubMed] [PMC] 
  39. Ross S, Maxwell S. Prescribing and the core curriculum for tomorrow's doctors: BPS curriculum in clinical pharmacology and prescribing for medical students. Br J Clin Pharmacol. 2012;74(4):644-61. [Crossref] [PubMed] [PMC] 
  40. Brinkman DJ, Tichelaar J, Okorie M, Bissell L, Christiaens T, Likic R, et al; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Pharmacology and Therapeutics Education in the European Union Needs Harmonization and Modernization: a cross-sectional survey among 185 medical schools in 27 countries. Clin Pharmacol Ther. 2017; 102(5):815-22. [Crossref] [PubMed] [PMC] 
  41. Brinkman DJ, Tichelaar J, Schutte T, Benemei S, B�ttiger Y, Chamontin B, et al; Working Group Research on CPT Education of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Essential competencies in prescribing: a first European cross-sectional study among 895 final-year medical students. Clin Pharmacol Ther. 2017;101(2): 281-9. [Crossref] [PubMed] [PMC] 
  42. Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, et al; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP). Key learning outcomes for clinical pharmacology and therapeutics education in Europe: a modified Delphi study. Clin Pharmacol Ther. 2018;104(2):317-25. [Crossref] [PubMed] [PMC] 
  43. Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743-59. [Crossref] [PubMed] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com